188 related articles for article (PubMed ID: 16480404)
21. What do heartburn sufferers expect from proton pump inhibitors when prescribed for the first time?
Kamolz T; Pointner R
Minerva Gastroenterol Dietol; 2004 Jun; 50(2):143-7. PubMed ID: 15722984
[TBL] [Abstract][Full Text] [Related]
22. What is the best pharmacologic approach to managing moderate to severe heartburn?
Melton ST; Cimmino A
J Fam Pract; 2001 Oct; 50(10):839. PubMed ID: 11674880
[No Abstract] [Full Text] [Related]
23. Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis.
Metz DC; Howden CW; Perez MC; Larsen L; O'Neil J; Atkinson SN
Aliment Pharmacol Ther; 2009 Apr; 29(7):742-54. PubMed ID: 19210298
[TBL] [Abstract][Full Text] [Related]
24. Treatment of gastroesophageal reflux disease: to step or not to step.
McGuigan JE
Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
[No Abstract] [Full Text] [Related]
25. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
26. Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Robinson M; Decktor DL; Maton PN; Sabesin S; Roufail W; Kogut D; Roberts W; McCullough A; Pardoll P; Saco L
Aliment Pharmacol Ther; 1993 Feb; 7(1):67-73. PubMed ID: 8439639
[TBL] [Abstract][Full Text] [Related]
27. Ranitidine versus cimetidine in the healing of erosive esophagitis.
McCarty-Dawson D; Sue SO; Morrill B; Murdock RH
Clin Ther; 1996; 18(6):1150-60. PubMed ID: 9001831
[TBL] [Abstract][Full Text] [Related]
28. A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.
Kobeissy AA; Hashash JG; Jamali FR; Skoury AM; Haddad R; El-Samad S; Ladki R; Aswad R; Soweid AM
World J Gastroenterol; 2012 May; 18(19):2390-5. PubMed ID: 22654431
[TBL] [Abstract][Full Text] [Related]
29. Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?
Robinson MG; Orr WC; McCallum R; Nardi R
Am J Gastroenterol; 1987 Jun; 82(6):519-22. PubMed ID: 3554990
[TBL] [Abstract][Full Text] [Related]
30. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
32. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
Weiser HF; Gubernatis G; Siewert JR
Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
[TBL] [Abstract][Full Text] [Related]
33. A false sense of security; symptom control does not predict healing of oesophagitis on proton pump inhibitors.
Tan VP; Wong BC
Aliment Pharmacol Ther; 2009 Aug; 30(3):307-8; author reply 308-9. PubMed ID: 19624463
[No Abstract] [Full Text] [Related]
34. Nonprescription doses of ranitidine are effective in the relief of episodic heartburn.
Ciociola AA; Pappa KA; Sirgo MA
Am J Ther; 2001; 8(6):399-408. PubMed ID: 11704778
[TBL] [Abstract][Full Text] [Related]
35. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
Wiklund I; Carlsson R; Carlsson J; Glise H
Scand J Gastroenterol; 2006 Mar; 41(3):288-93. PubMed ID: 16497615
[TBL] [Abstract][Full Text] [Related]
36. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
Katz PO
Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
[TBL] [Abstract][Full Text] [Related]
38. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
39. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
Fennerty MB; Johnson DA
MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
[TBL] [Abstract][Full Text] [Related]
40. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
